Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia

Clive S. Zent, Neil Elliot Kay

Research output: Contribution to journalArticle

9 Scopus citations


Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course and outcome. Recent advances in the diagnosis and molecular characterization of CLL permit improved prediction of disease prognosis, which could result in better management. We review the biology and diagnosis of CLL and the role of analysis of immunoglobulin heavy-chain variable region mutation status, molecular cytogenetics (interphase fluorescence in situ hybridization), and the expression of CD38 and ZAP-70 in the evaluation and management of patients with CLL.

Original languageEnglish (US)
Pages (from-to)348-354
Number of pages7
JournalCurrent Oncology Reports
Issue number5
StatePublished - Sep 2004


ASJC Scopus subject areas

  • Medicine(all)

Cite this